Johnson & Johnson Comprehensive Income 2010-2024 | JNJ

Johnson & Johnson comprehensive income for the quarter ending June 30, 2024 was $-11.253B, a 14.33% decline year-over-year.

  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.
  • Johnson & Johnson comprehensive income for 2022 was $-12.967B, a 0.7% decline from 2021.
  • Johnson & Johnson comprehensive income for 2021 was $-13.058B, a 14.33% decline from 2020.

Johnson & Johnson Comprehensive Income 2010-2024 | JNJ

  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.
  • Johnson & Johnson comprehensive income for 2022 was $-12.967B, a 0.7% decline from 2021.
  • Johnson & Johnson comprehensive income for 2021 was $-13.058B, a 14.33% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B